Save your place

Sign in to WhoBought

Please try again later.

Jim Simons's Harmony Biosciences Holdings, Inc. (HRMY) position

Yes: as of Q1 2026, Jim Simons holds 1.1M shares of HRMY worth $30M (0.0% of the disclosed portfolio). Last quarter the position was increased by 0.6%. First disclosed Q2 2021.
View full portfolio →
Current value
$30M
Shares held
1.1M
% of portfolio
0.0%
Est. average buy price (i)
$32.48
est. since Q4 2023
Quarter-end price
$28.01

Estimated trade prices

Average price in quarters with purchases
$35.80
Average prices in quarters with sales
  • Q4 2025: $32.88 (67K shares sold)
  • Q3 2024: $35.12 (103K shares sold)
  • Q3 2023: $34.72 (118K shares sold)
  • Q2 2023: $34.52 (55K shares sold)

HRMY price vs Simons's position

1Y 3Y 5Y MAX
Dates
$20$40$6020222023202420252026Added 28K shares (233.9%) · Q3 2021. Average closing price $32.20 · Price range $25.68–$38.6128KsharespurchasedAdded 95K shares (242.1%) · Q4 2021. Average closing price $39.86 · Price range $34.09–$43.9195KsharespurchasedAdded 8K shares (5.7%) · Q1 2022. Average closing price $40.79 · Price range $33.14–$51.138KsharespurchasedAdded 149K shares (104.8%) · Q2 2022. Average closing price $45.02 · Price range $33.54–$52.15149KsharespurchasedAdded 33K shares (11.4%) · Q3 2022. Average closing price $48.78 · Price range $42.06–$55.4533KsharespurchasedAdded 18K shares (5.4%) · Q4 2022. Average closing price $54.98 · Price range $45.40–$60.9118KsharespurchasedSold 55K shares (11.9%) · Q2 2023. Average closing price $34.52 · Price range $30.50–$37.4055KsharessoldSold 118K shares (28.8%) · Q3 2023. Average closing price $34.72 · Price range $31.89–$39.03118KsharessoldAdded 122K shares (47.0%) · Q1 2024. Average closing price $32.10 · Price range $29.93–$35.06122KsharespurchasedAdded 216K shares (56.7%) · Q2 2024. Average closing price $30.07 · Price range $28.81–$33.01216KsharespurchasedSold 103K shares (17.3%) · Q3 2024. Average closing price $35.12 · Price range $30.00–$40.00103KsharessoldAdded 76K shares (15.4%) · Q4 2024. Average closing price $34.36 · Price range $31.86–$41.4976KsharespurchasedAdded 272K shares (47.8%) · Q1 2025. Average closing price $35.85 · Price range $32.18–$40.46272KsharespurchasedAdded 89K shares (10.6%) · Q2 2025. Average closing price $32.17 · Price range $27.94–$35.9189KsharespurchasedAdded 208K shares (22.3%) · Q3 2025. Average closing price $34.45 · Price range $26.76–$38.05208KsharespurchasedSold 67K shares (5.9%) · Q4 2025. Average closing price $32.88 · Price range $25.90–$40.5167KsharessoldAdded 7K shares (0.6%) · Q1 2026. Average closing price $32.79 · Price range $26.54–$38.557Ksharespurchased← Earlier —1 purchase
Average closing price · filing quarter
$32.79
Price range · filing quarter
$26.54 – $38.55
Sign in to see who bought

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Added +7K +$226K +0.6% 1.1M May 14, 2026
Q4 2025 Reduced −67K −$2.2M −5.9% 1.1M Feb 12, 2026
Q3 2025 Added +208K +$7.2M +22.3% 1.1M Nov 13, 2025
Q2 2025 Added +89K +$2.9M +10.6% 929K Aug 13, 2025
Q1 2025 Added +272K +$9.7M +47.8% 840K May 14, 2025
Q4 2024 Added +76K +$2.6M +15.4% 569K Feb 13, 2025
Q3 2024 Reduced −103K −$3.6M −17.3% 493K Nov 13, 2024
Q2 2024 Added +216K +$6.5M +56.7% 596K Aug 9, 2024
Q1 2024 Added +122K +$3.9M +47.0% 380K May 13, 2024
Q4 2023 First covered – – – 258K Feb 13, 2024
Q3 2023 Reduced −118K −$4.1M −28.8% 292K Nov 14, 2023
Q2 2023 Reduced −55K −$1.9M −11.9% 410K Aug 11, 2023
Q1 2023 First covered – – – 466K May 12, 2023
Q4 2022 Added +18K +$973K +5.4% 343K Feb 13, 2023
Q3 2022 Added +33K +$1.6M +11.4% 325K Nov 14, 2022
Q2 2022 Added +149K +$6.7M +104.8% 292K Aug 12, 2022
Q1 2022 Added +8K +$314K +5.7% 142K May 13, 2022
Q4 2021 Added +95K +$3.8M +242.1% 135K Feb 11, 2022
Q3 2021 Added +28K +$889K +233.9% 39K Nov 12, 2021
Q2 2021 New +12K +$354K – 12K Aug 13, 2021
Data through Q1 2026 · filed May 14, 2026
20 grouped rows from 20 quarters

More Simons positions

United Therapeutics Corporation(UTHR)
$1.1B
1.7% of portfolio

Palantir Technologies Inc.(PLTR)
$997M
1.6% of portfolio

Apple Inc.(AAPL)
$778M
1.2% of portfolio

Kinross Gold Corporation(KGC)
$780M
1.2% of portfolio

Micron Technology, Inc.(MU)
$731M
1.1% of portfolio

VeriSign, Inc.(VRSN)
$700M
1.1% of portfolio

Common questions

Does Jim Simons own HRMY?

Yes. As of Q1 2026, Jim Simons disclosed 1.1M shares of HRMY, worth $30M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Jim Simons buy HRMY?

Jim Simons first disclosed a HRMY position in Q2 2021; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Jim Simons sell HRMY?

The quarter-by-quarter table above shows each sale and reduction Jim Simons disclosed in HRMY. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of HRMY does Jim Simons own?

Jim Simons disclosed 1.1M shares of HRMY as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Jim Simons pay for HRMY?

Jim Simons began building the HRMY position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.